An increased risk of PC has been found in Ashkenazi Jews in whom more than 2% carry germline mutations in BRCA1 or BRCA2 and in PC with intraductal histology that appear to have greater genomic instability compared to those with adenocarcinoma histology (35–38). This evidence concerns the gene BRCA2 and pachyonychia congenita.